Furthermore, radiobiologic studies in tumors bearing Fancd2−/− and FancG−/− mice may lead to the clinical translation of JP4-039/F15 as a potential radioprotectant during radiotherapy of Fanconi anemia patients, or other patients with genetic defects in DNA repair. This evidence concerns the gene FANCD2 and Fanconi anemia.